| (₹ crores) | Q2FY26 | Q1FY26 | Q2FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 122.31 | 110.54 | 98.60 | 10.6% | 24.0% |
Total Expenses | 109.34 | 98.70 | 85.28 | 10.8% | 28.2% |
Profit Before Tax | 12.96 | 11.84 | 13.33 | 9.5% | -2.8% |
Tax | 3.34 | 2.60 | 3.52 | 28.5% | -5.1% |
Profit After Tax | 9.63 | 9.24 | 9.81 | 4.2% | -1.8% |
Earnings Per Share | 15.58 | 14.96 | 15.88 | 4.1% | -1.9% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
NGL Fine Chem Ltd is a company engaged in the manufacturing of pharmaceuticals, primarily focusing on veterinary active pharmaceutical ingredients (APIs). The company operates within the pharmaceutical industry, providing essential products that cater to both domestic and international markets. NGL Fine Chem Ltd has been steadily growing its presence in the market, though specific recent developments are not provided in the current data set. As a player in the pharmaceutical sector, it is positioned to leverage the growing demand for healthcare products globally.
In the second quarter of the fiscal year 2026 (Q2FY26), NGL Fine Chem Ltd reported a total income of ₹122.31 crores, showing a 10.6% increase compared to ₹110.54 crores in the previous quarter (Q1FY26) and a 24.0% increase from ₹98.60 crores in the same quarter of the previous fiscal year (Q2FY25). This upward trend in revenue indicates a strong quarter-over-quarter and year-over-year growth in total income, reflecting a robust performance in revenue generation. The company's ability to increase its total income over both short and long-term periods is noteworthy within the provided data.
The company's profitability metrics reveal a profit before tax of ₹12.96 crores for Q2FY26, which marks a 9.5% increase from ₹11.84 crores in Q1FY26, but a slight decrease of 2.8% compared to ₹13.33 crores in Q2FY25. The tax expenses stood at ₹3.34 crores, showing a significant quarter-over-quarter increase of 28.5% from ₹2.60 crores in Q1FY26 and a decrease of 5.1% from ₹3.52 crores in Q2FY25. Consequently, profit after tax for Q2FY26 was ₹9.63 crores, representing a 4.2% increase from the previous quarter's ₹9.24 crores and a marginal decline of 1.8% from ₹9.81 crores in the same quarter of the previous year. Earnings per share for Q2FY26 were ₹15.58, reflecting similar percentage changes as the profit after tax.
Analyzing the operating metrics, NGL Fine Chem Ltd's total expenses for Q2FY26 were reported at ₹109.34 crores. This represents a 10.8% increase from ₹98.70 crores in Q1FY26 and a 28.2% increase from ₹85.28 crores in Q2FY25. The increase in expenses reflects operational activity that corresponds with the rise in revenue. The financial data shows that while the company experienced growth in both income and expenses, there was a slightly lower growth rate in profit before tax compared to total income, indicating cost influences on profitability. The changes in tax expenses and their impact on net profit further highlight the company's fiscal dynamics during the quarter.
NGL Fine Chem Ltd announced its Q2 FY 2025-26 results on 16 November, 2025.
NGL Fine Chem Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of NGL Fine Chem Ltd Q2 FY 2025-26 results include:
NGL Fine Chem Ltd reported a net profit of ₹9.63 crore in Q2 FY 2025-26, reflecting a -1.8% year-over-year growth.
NGL Fine Chem Ltd posted a revenue of ₹122.31 crore in Q2 FY 2025-26.